HRT Financial
WHWK icon

HRT Financial’s Whitehawk Therapeutics WHWK Stock Holding History

HRT Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,935
Closed -$120K – 5659
2026
Q1 		$120K Buy
+34,935
New +$109K ﹤0.01% 3317
2024
Q3 		– Sell
-28,172
Closed -$41K – 3298
2024
Q2 		$41K Buy
+28,172
New +$52.2K ﹤0.01% 1862
2022
Q4 		– Sell
-31,737
Closed -$448K – 3307
2022
Q3 		$448K Sell
31,737
-20,385
-39% -$268K ﹤0.01% 1712
2022
Q2 		$642K Buy
+52,122
New +$774K 0.01% 1309

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Acuta Capital Partners
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QVT Financial
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KVP Capital Advisors
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's WHWK Position: Q2 2026 in Review

HRT Financial sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 34,935 shares — an estimated $120K sold.

HRT Financial first reported a position in WHWK in Q2 2022 and held it in 4 quarters. The position peaked at $642K in Q2 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • HRT Financial reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 34,935 Whitehawk Therapeutics shares in Q2 2026, an estimated $120K.
  • HRT Financial first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 4 quarters.
  • HRT Financial's Whitehawk Therapeutics position peaked at $642K in Q2 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.